Literature DB >> 32687841

Urologic Services in Public Hospitals Suffered a Greater Detriment Than Private Hospitals During the Battle of COVID-19.

William Lay Keat Ong1, Sivaneswaran Lechmiannandan2, Stacy Loeb3, Jeremy Yuen-Chun Teoh4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32687841      PMCID: PMC7367783          DOI: 10.1016/j.urology.2020.07.010

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


× No keyword cloud information.
Dear editor The coronavirus disease-19 (COVID-19) has been regarded as the most challenging global health crisis since its declaration as pandemic on March 11, 2020 by the World Health Organization (WHO). As COVID-19 swept through continents, health care services across all specialties, including urology were disrupted. Recently, a global survey on the impact of COVID-19 on urologic services was conducted, with a total of 1004 responses from urology health care professionals reviewed. Results showed that COVID-19 had a profound negative impact on the delivery of urologic care globally. The level of setbacks corresponded to the degree of COVID-19 outbreak. The severity of this impact, however, may not be representative of the various urologic establishments. We thus performed a post hoc analysis to compare the severity of COVID-19 effects on urology services between the public and private institutions. After excluding participants who had mixed public and private practices, 891 participants remained for the analysis. About 71.8% were from public hospitals and 16.9% were from private hospitals. Majority of respondents were 30-49 years old and were predominantly consultant urologists. About 57.4% of them have been in practice up to 10 years. The demographic characteristics of survey respondents are shown in Supplementary Table 1. There were more public than private hospital-based respondents working in COVID-19 centers (85.8% vs 50.8%, P < .001). About 45.9% from public and 25.4% from private hospitals reported staffs diagnosed with COVID-19 infection (P < .001). About 30.2% from public and 9% from private hospitals were deployed to manage COVID-19 patients (P < .001), with manpower shortage posing more concerns in the public hospitals (45.9% vs 25.4%, P < .001). Although most hospitals were equipped with personal protective equipment (PPE) (surgical mask, N95, bodysuits, splash guard or face shield, goggles, and others), only 33.1% of public and 36.9% of private respondents confirmed the sufficiency of PPE in their centers (P = .025). About 36.5% of public and 20.5% of private respondents were adequately trained to use PPE. Concerningly, more public than private (24.5% vs 7.4%, P < .001) administrative authorities prohibited health care workers from sharing their experience on conventional and social media (Table 1 ).
Table 1

Key findings of the global survey comparing public and private hospitals

QuestionsPublic Hospital (%)Private Hospital (%)P Value
Has your hospital been managing patients with COVID-19?85.850.8<.001
Has any of your hospital staff been diagnosed with COVID-19?45.925.4<.001
Is your department facing any internal manpower problem?28.024.6.001
Have you been deployed to take care of patients with confirmed COVID-19?30.29.0<.001
Do you feel that the personal protective equipment you are provided with is sufficient?33.136.9.025
Have you received formal training in decontamination protocols?36.520.5<.001
Do you think the postponement of clinical service will affect the treatment/ survival outcomes of your patients?52.539.8.025
Do you think the accumulated workload can be dealt with in a timely manner after the COVID-19 outbreak?42.661.9.001
Has your institution instructed you not to share your experience on conventional media or social media?24.57.4<.001
Has COVID-19 affected your income or do you expect a reduction in salary?49.788.5<.001
Key findings of the global survey comparing public and private hospitals Finally, 52.5% from public and 39.8% from private believed that postponement of clinical services would affect their patients’ treatment and survival outcomes (P = .025). Only 42.6% from the public hospitals (vs 61.9% from the private hospitals, P = .001) had the confidence to deal with accumulated workload in a timely manner after the pandemic. In terms of income, however, private urology professionals (88.5%) suffered significant salary cutbacks compared to their colleagues in public (49.7%; P < .001). Urologic patients screened negative for COVID-19 could be referred to non-COVID-19 private hospitals to avoid delay in intervention. Private institutions may also cope better to deal with the backlog once COVID-19 has settled. It may help alleviate the potential financial problems that private practice providers may be facing, given the significant salary reduction during this critical period. Implementation of public-private partnership strategies in tackling this matter appears imperative. In summary, public hospitals suffered greater losses of manpower, inadequacy of PPE and restriction of media contact while health care professionals in the private hospitals suffered greater loss financially. Profound repercussions are to be anticipated and necessitate reallocation of resources by financing bodies to halt the foreseen exhaustion.

SUPPLEMENTARY MATERIALS

  2 in total

Review 1.  COVID-19 and urology: a comprehensive review of the literature.

Authors:  Stefano Puliatti; Ahmed Eissa; Radwa Eissa; Marco Amato; Elio Mazzone; Paolo Dell'Oglio; Maria Chiara Sighinolfi; Ahmed Zoeir; Salvatore Micali; Giampaolo Bianchi; Vipul Patel; Peter Wiklund; Rafael F Coelho; Jean-Christophe Bernhard; Prokar Dasgupta; Alexandre Mottrie; Bernardo Rocco
Journal:  BJU Int       Date:  2020-05-12       Impact factor: 5.588

2.  A Global Survey on the Impact of COVID-19 on Urological Services.

Authors:  Jeremy Yuen-Chun Teoh; William Lay Keat Ong; Daniel Gonzalez-Padilla; Daniele Castellani; Justin M Dubin; Francesco Esperto; Riccardo Campi; Kalyan Gudaru; Ruchika Talwar; Zhamshid Okhunov; Chi-Fai Ng; Nitesh Jain; Vineet Gauhar; Martin Chi-Sang Wong; Marcelo Langer Wroclawski; Yiloren Tanidir; Juan Gomez Rivas; Ho-Yee Tiong; Stacy Loeb
Journal:  Eur Urol       Date:  2020-05-26       Impact factor: 20.096

  2 in total
  4 in total

1.  Risks of AKI and Major Adverse Clinical Outcomes in Patients with Severe Acute Respiratory Syndrome or Coronavirus Disease 2019.

Authors:  Jeremy Yuen-Chun Teoh; Terry Cheuk-Fung Yip; Grace Chung-Yan Lui; Vincent Wai-Sun Wong; Viola Chi-Ying Chow; Tracy Hang-Yee Ho; Timothy Chun-Man Li; Yee-Kit Tse; Peter Ka-Fung Chiu; Chi-Fai Ng; David Shu-Cheong Hui; Henry Lik-Yuen Chan; Cheuk-Chun Szeto; Grace Lai-Hung Wong
Journal:  J Am Soc Nephrol       Date:  2021-01-22       Impact factor: 10.121

2.  Delayed surgery for localised and metastatic renal cell carcinoma: a systematic review and meta-analysis for the COVID-19 pandemic.

Authors:  Vinson Wai-Shun Chan; Wei Shen Tan; Jeffrey J Leow; Wei Phin Tan; William Lay Keat Ong; Peter Ka-Fung Chiu; Pratik Gurung; Giacomo Maria Pirola; Luca Orecchia; Matthew Ping Chao Liew; Hsiang-Ying Lee; Yuding Wang; I-Hsuan Alan Chen; Daniele Castellani; Marcelo Langer Wroclawski; Nikhil Mayor; Niranjan J Sathianathen; Isaac Braga; Zhenbang Liu; Dora Moon; Kari Tikkinen; Ashish Kamat; Max Meng; Vincenzo Ficarra; Gianluca Giannarini; Jeremy Yuen-Chun Teoh
Journal:  World J Urol       Date:  2021-05-24       Impact factor: 4.226

3.  Early outcomes of short-course low intensity shockwave therapy (LiSWT) for erectile dysfunction: A prospective, randomized, double-blinded, sham-controlled study in Malaysia.

Authors:  William Lay Keat Ong; Sivaneswaran Lechmiannandan; Yen Li Lim; Devindran Manoharan; Say Bob Lee
Journal:  Andrologia       Date:  2022-07-01       Impact factor: 2.532

Review 4.  A systematic review and meta-analysis on delaying surgery for urothelial carcinoma of bladder and upper tract urothelial carcinoma: Implications for the COVID19 pandemic and beyond.

Authors:  Jeffrey J Leow; Wei Shen Tan; Wei Phin Tan; Teck Wei Tan; Vinson Wai-Shun Chan; Kari A O Tikkinen; Ashish Kamat; Shomik Sengupta; Maxwell V Meng; Shahrokh Shariat; Morgan Roupret; Karel Decaestecker; Nikhil Vasdev; Yew Lam Chong; Dmitry Enikeev; Gianluca Giannarini; Vincenzo Ficarra; Jeremy Yuen-Chun Teoh
Journal:  Front Surg       Date:  2022-10-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.